Abstract
Hepatotoxicity is regarded as a rare side effect of amphotericin B therapy. A patient with acute myelogenous leukemia who had normal liver function was treated with amphotericin B for fungal pneumonia. While he was receiving the drug at high dosages asymptomatic elevation of the levels of alkaline phosphatase, serum glutamic oxaloacetic transaminase, serum glutamic pyruvic transaminase, lactic dehydrogenase and bilirubin was noted. The levels returned to normal when the drug was discontinued. Rechallenge with a lower dosage prompted a rapid rise in the levels, with subsequent return to normal when the medication was withdrawn.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Atkinson A. J., Jr, Bennett J. E. Amphotericin B pharmacokinetics in humans. Antimicrob Agents Chemother. 1978 Feb;13(2):271–276. doi: 10.1128/aac.13.2.271. [DOI] [PMC free article] [PubMed] [Google Scholar]
- BRANDRISS M. W., WOLFF S. M., MOORES R., STOHLMAN F., Jr ANEMIA INDUCED BY AMPHOTERICIN B. JAMA. 1964 Aug 31;189:663–666. doi: 10.1001/jama.1964.03070090013003. [DOI] [PubMed] [Google Scholar]
- BUTLER W. T., BENNETT J. E., ALLING D. W., WERTLAKE P. T., UTZ J. P., HILL G. J., 2nd NEPHROTOXICITY OF AMPHOTERICIN B; EARLY AND LATE EFFECTS IN 81 PATIENTS. Ann Intern Med. 1964 Aug;61:175–187. doi: 10.7326/0003-4819-61-2-175. [DOI] [PubMed] [Google Scholar]
- Bennett J. E. Chemotherapy of systemic mycoses (first of two parts). N Engl J Med. 1974 Jan 3;290(1):30–32. doi: 10.1056/NEJM197401032900107. [DOI] [PubMed] [Google Scholar]
- CARNECCHIA B. M., KURTZKE J. F. Fatal toxic reaction to amphotericin B in cryptococcal meningo-encephalitis. Ann Intern Med. 1960 Nov;53:1027–1036. doi: 10.7326/0003-4819-53-5-1027. [DOI] [PubMed] [Google Scholar]
- Feinstein A. R. Clinical biostatistics. 28. The biostatistical problems of pharmaceutical surveillance. Clin Pharmacol Ther. 1974 Jul;16(1):110–123. doi: 10.1002/cpt1974161part1110. [DOI] [PubMed] [Google Scholar]
- Karch F. E., Smith C. L., Kerzner B., Mazzullo J. M., Weintraub M., Lasagna L. Adverse drug reactions-a matter of opinion. Clin Pharmacol Ther. 1976 May;19(5 Pt 1):489–492. doi: 10.1002/cpt1976195part1489. [DOI] [PubMed] [Google Scholar]
- Medoff G., Kobayashi G. S. Strategies in the treatment of systemic fungal infections. N Engl J Med. 1980 Jan 17;302(3):145–155. doi: 10.1056/NEJM198001173020304. [DOI] [PubMed] [Google Scholar]